Allosteric Enhancers of A1 Adenosine Receptors Increase Receptor-G Protein Coupling and Counteract Guanine Nucleotide Effects on Agonist Binding
- 1 December 2003
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 64 (6) , 1557-1564
- https://doi.org/10.1124/mol.64.6.1557
Abstract
Endogenous ligands of G protein-coupled receptors bind to orthosteric sites that are topologically distinct from allosteric sites. Certain aminothiophenes such as (2-amino-4,5-dimethyl-3-thienyl)-[3-(trifluromethyl)-phenyl]-methanone (PD81,723) and 2-amino-4,5,6,7-tetrahydro-benzo[b]thiophen-3-yl)-biphenyl-4-yl-methanone (ATL525) are positive allosteric regulators, or enhancers, of the human A1 adenosine receptor (A1AR). In equilibrium binding assays, 125I-N6-aminobenzyladenosine (125I-ABA) binds to two affinity states of A1AR with KD-high (0.33 μM) and KD-low (∼10 nM). Enhancers have little effect on KD-high but convert all A1AR binding sites to the high-affinity state. Enhancers decrease the potency of guanosine 5′-O-(3-thio)triphosphate (GTPγS) as an inhibitor of agonist binding by 100-fold and increase agonist-stimulated guanine nucleotide exchange. The association of 125I-ABA to high-affinity receptors on Chinese hamster ovary (CHO)-hA1 membranes does not follow theoretical single-site association kinetics but is approximated by a bi-exponential equation with t1/2 values of 1.85 and 12.8 min. Allosteric enhancers selectively increase the number of slow binding sites, possibly by stabilizing newly formed receptor-G protein complexes. A new rapid assay method scores enhancer activity on a scale from 0 to 100 based on their ability to prevent the rapid dissociation of 125I-ABA from A1AR in response to GTPγS. Compared with PD81,723, ATL525 (100 μM) scores higher (27 versus 79) and has less antagonist activity. ATL525 functionally enhances A1 signaling to inhibit cAMP accumulation in CHO-hA1 cells. These data suggest that simultaneously binding orthosteric and allosteric enhancer ligands convert the A1AR from partly to fully coupled to G proteins and prevents rapid uncoupling upon binding of GTPγS.Keywords
This publication has 22 references indexed in Scilit:
- 2-Amino-3-benzoylthiophene Allosteric Enhancers of A1 Adenosine Agonist Binding: New 3, 4-, and 5-ModificationsJournal of Medicinal Chemistry, 2003
- G Protein-Coupled Receptor Allosterism and ComplexingPharmacological Reviews, 2002
- Allosteric binding sites on cell-surface receptors: novel targets for drug discoveryNature Reviews Drug Discovery, 2002
- Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptorBiochemical Pharmacology, 2001
- Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptorBioorganic & Medicinal Chemistry Letters, 2000
- Differential effects of the adenosine A1 receptor allosteric enhancer PD 81,723 on agonist binding to brain and adipocyte membranesBrain Research, 1999
- Reconstitution of Bovine A1 Adenosine Receptors and G Proteins in Phospholipid Vesicles: βγ-Subunit Composition Influences Guanine Nucleotide Exchange and Agonist BindingBiochemistry, 1997
- The allosteric enhancer, PD 81,723, stabilizes human A1 adenosine receptor coupling to G proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- Allosteric enhancer PD 81,723 acts by novel mechanism to potentiate cardiac actions of adenosine.Circulation Research, 1994
- Functional activity of the adenosine binding enhancer, PD 81,723, in the in vitro hippocampal sliceBrain Research, 1991